BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 38720384)

  • 1. A radiomics-based nomogram may be useful for predicting telomerase reverse transcriptase promoter mutation status in adult glioblastoma.
    Li Y; Chen L; Huang L; Li X; Huang Q; Tang L; Huang Z; Zhu L; Li T
    Brain Behav; 2024 May; 14(5):e3528. PubMed ID: 38798094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the progression-free survival of gastrointestinal stromal tumors after imatinib therapy through multi-sequence magnetic resonance imaging.
    Yang L; Zhang D; Zheng T; Liu D; Fang Y
    Abdom Radiol (NY); 2024 Mar; 49(3):801-813. PubMed ID: 38006414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the malignancy of extremity soft-tissue tumors by an ultrasound-based radiomics signature.
    Li A; Hu Y; Cui XW; Ye XH; Peng XJ; Lv WZ; Zhao CK
    Acta Radiol; 2024 May; 65(5):470-481. PubMed ID: 38321752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Multimodality Model Based on Whole-Slide Imaging and Biparametric MRI for Predicting Postoperative Biochemical Recurrence in Prostate Cancer.
    Hu C; Qiao X; Huang R; Hu C; Bao J; Wang X
    Radiol Imaging Cancer; 2024 May; 6(3):e230143. PubMed ID: 38758079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarculator: how to improve further prognostication of all sarcomas.
    Borghi A; Gronchi A
    Curr Opin Oncol; 2024 Jul; 36(4):253-262. PubMed ID: 38726834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-institutional validation of a radiomics signature for identification of postoperative progression of soft tissue sarcoma.
    Yu Y; Guo H; Zhang M; Hou F; Yang S; Huang C; Duan L; Wang H
    Cancer Imaging; 2024 May; 24(1):59. PubMed ID: 38720384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Learning Radiomics Nomogram to Predict Lung Metastasis in Soft-Tissue Sarcoma: A Multi-Center Study.
    Liang HY; Yang SF; Zou HM; Hou F; Duan LS; Huang CC; Xu JX; Liu SL; Hao DP; Wang HX
    Front Oncol; 2022; 12():897676. PubMed ID: 35814362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
    Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
    Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting cancer outcomes with radiomics and artificial intelligence in radiology.
    Bera K; Braman N; Gupta A; Velcheti V; Madabhushi A
    Nat Rev Clin Oncol; 2022 Feb; 19(2):132-146. PubMed ID: 34663898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep learning radiomic nomogram to predict recurrence in soft tissue sarcoma: a multi-institutional study.
    Liu S; Sun W; Yang S; Duan L; Huang C; Xu J; Hou F; Hao D; Yu T; Wang H
    Eur Radiol; 2022 Feb; 32(2):793-805. PubMed ID: 34448928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and External Validation of Deep-Learning-Based Tumor Grading Models in Soft-Tissue Sarcoma Patients Using MR Imaging.
    Navarro F; Dapper H; Asadpour R; Knebel C; Spraker MB; Schwarze V; Schaub SK; Mayr NA; Specht K; Woodruff HC; Lambin P; Gersing AS; Nyflot MJ; Menze BH; Combs SE; Peeken JC
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Resonance Imaging-Based Radiomics Nomogram for Prediction of the Histopathological Grade of Soft Tissue Sarcomas: A Two-Center Study.
    Yan R; Hao D; Li J; Liu J; Hou F; Chen H; Duan L; Huang C; Wang H; Yu T
    J Magn Reson Imaging; 2021 Jun; 53(6):1683-1696. PubMed ID: 33604955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade.
    Vaidya P; Bera K; Patil PD; Gupta A; Jain P; Alilou M; Khorrami M; Velcheti V; Madabhushi A
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33051342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can we combat multicenter variability in MR radiomics? Validation of a correction procedure.
    Orlhac F; Lecler A; Savatovski J; Goya-Outi J; Nioche C; Charbonneau F; Ayache N; Frouin F; Duron L; Buvat I
    Eur Radiol; 2021 Apr; 31(4):2272-2280. PubMed ID: 32975661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
    Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Chiu KWH; Fu J; Vardhanabhuti V
    JAMA Netw Open; 2020 Sep; 3(9):e2015927. PubMed ID: 32910196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.
    Gamboa AC; Gronchi A; Cardona K
    CA Cancer J Clin; 2020 May; 70(3):200-229. PubMed ID: 32275330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer.
    Jiang Y; Wang H; Wu J; Chen C; Yuan Q; Huang W; Li T; Xi S; Hu Y; Zhou Z; Xu Y; Li G; Li R
    Ann Oncol; 2020 Jun; 31(6):760-768. PubMed ID: 32240794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and assessment of an individualized nomogram to predict colorectal cancer liver metastases.
    Li M; Li X; Guo Y; Miao Z; Liu X; Guo S; Zhang H
    Quant Imaging Med Surg; 2020 Feb; 10(2):397-414. PubMed ID: 32190566
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.